Search

everythinglearnresearchcommunity

for

Search:↓

The nanofiber membranes effectively promote wound healing and have strong antibacterial properties.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Five FDA-approved drugs may help block COVID-19 virus entry.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

The new collagen and tannic acid hydrogel effectively stops bleeding and aids tissue repair better than current options.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Testosterone, 4-hydroxyandrostenedione, and finasteride affect blood clotting differently in stressed heart conditions.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Captopril reduces heart mass, while minoxidil has opposite effects and side effects.

New compounds show promise as nonsteroidal treatments for hair loss.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Atropine and neosynephrine effectively prevent floppy iris syndrome during cataract surgery.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Human dermal papilla cell vesicles can reduce skin fibrosis in mice.